Prostate Cancer - Results from #21180

Improved outcomes in elderly patients with metastatic castration-resistant prostate cancer treated with the androgen receptor inhibitor enzalutamide: Results from the phase III AFFIRM trial - Abstract February 26, 2014

Clinical evaluation of abiraterone in the treatment of metastatic prostate cancer - Abstract February 26, 2014

Impact of prednisone on toxicities and survival in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis of randomized clinical trials - Abstract February 26, 2014

Does regular zoledronic acid change the bone turnover of the jaw in men with metastatic prostate cancer: A possible clue to the pathogenesis of bisphosphonate related osteonecrosis of the jaw? - Abstract February 25, 2014

Bone metastases in castration-resistant prostate cancer: Associations between morphologic CT patterns, glycolytic activity, and androgen receptor expression on PET and overall survival - Abstract February 25, 2014

Salvage low-dose-rate brachytherapy for prostate cancer local recurrence after radical prostatectomy: Our first three patients - Abstract February 25, 2014

Prostate cancer boost using high-dose-rate brachytherapy: Early toxicity analysis of 3 different fractionation schemes - Abstract February 25, 2014

Prostate-specific antigen bounce predicts for a favorable prognosis following brachytherapy: A meta-analysis - Abstract February 25, 2014

Time to failure after definitive therapy for prostate cancer: Implications for importance of aggressive local treatment - Abstract February 25, 2014

Localized prostate cancer detection with (18)F FACBC PET/CT: Comparison with MR imaging and histopathologic analysis - Abstract February 25, 2014

Prostate cancer aggressiveness: Assessment with whole-lesion histogram analysis of the apparent diffusion coefficient - Abstract February 25, 2014

A case of metastatic cancer with markedly elevated PSA level that was not detected by repeat prostate biopsy - Abstract February 25, 2014

Long-term results of radical prostatectomy with immediate adjuvant androgen deprivation therapy for pT3N0 prostate cancer - Abstract February 25, 2014

Metastatic castration-resistant prostate cancer. Part 2: Helping patients make informed choices and managing treatment side effects - Abstract February 25, 2014

Interfraction prostate movement in bone alignment after rectal enema for radiotherapy - Abstract February 24, 2014

The fluctuation of PCA3 score in men undergoing first or repeat prostate biopsies - Abstract February 24, 2014

Therapeutic modulation of prostate cancer metastasis - Abstract February 24, 2014

Survival benefit of definitive therapy in patients with clinically advanced prostate cancer: Estimations of the number needed to treat based on competing-risks analysis - Abstract February 24, 2014

Can supervised exercise prevent treatment toxicity in prostate cancer patients initiating androgen deprivation therapy: A randomised controlled trial - Abstract February 24, 2014

The role of magnetic resonance imaging in delineating clinically significant prostate cancer - Abstract February 24, 2014

Page 1060 of 1437